Her2 Expressing Solid Tumors clinical trials

Explore recruiting her2 expressing solid tumors clinical trials.

Recruiting her2 expressing solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Her2 Expressing Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2 Study of BDC-1001 as a Single Agent and in Combination with Nivolumab in Patients with Advanced HER2-Expressing Solid Tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

C5731005 _ A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2

Italy, France, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, open-label, multicenter study to evaluate efficacy and safety of zanidatamab for the treatment of participants with previously treated HER2-expressing solid tumors (DiscovHER PAN-206)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Her2 Expressing Solid Tumors trials by city

Her2 Expressing Solid Tumors in Toronto Her2 Expressing Solid Tumors in Vancouver Her2 Expressing Solid Tumors in Montreal Her2 Expressing Solid Tumors in Calgary Her2 Expressing Solid Tumors in Edmonton Her2 Expressing Solid Tumors in Ottawa Her2 Expressing Solid Tumors in Winnipeg Her2 Expressing Solid Tumors in Quebec City Her2 Expressing Solid Tumors in Hamilton Her2 Expressing Solid Tumors in Kitchener Her2 Expressing Solid Tumors in London Her2 Expressing Solid Tumors in Halifax Her2 Expressing Solid Tumors in New York Her2 Expressing Solid Tumors in Los Angeles Her2 Expressing Solid Tumors in Chicago Her2 Expressing Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease